Literature DB >> 3700618

Endogenous activity of phospholipases A and C in Ureaplasma urealyticum.

N S De Silva, P A Quinn.   

Abstract

The results of recent studies support the concept that Ureaplasma urealyticum may be a major cause of perinatal infection in both term and preterm infants. It has been postulated that phospholipase degradation of placental phospholipids by microorganisms triggers the onset of premature labor. Since the presence of ureaplasmas in placentas is associated with pregnancy loss, prematurity, and neonatal morbidity, we assayed U. urealyticum for the presence of phospholipase A1, A2, and C activities. Phospholipase A1 activity was low in lysates of exponential-phase cells of U. urealyticum. Phospholipase A2 activity was present and was 100-fold higher than the activity of phospholipase A1 in serotypes 3,4, and 8. The total activity and specific activity of phospholipase A2 in serotype 8 were nearly threefold higher than the activities in serotypes 3 and 4. Cell lysates of all three serotypes showed the presence of phospholipase C activity during the exponential phase of growth, and no significant difference in activity was observed among the three serotypes. In stationary-phase cells the phospholipase C activity was 10-fold lower than the activity in exponential-phase cells. Our results demonstrate that phospholipase activities are present in U. urealyticum cells and that the specific activities of phospholipase A2 differed among the three serotypes tested, while the activities of phospholipases A1 and C were similar.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3700618      PMCID: PMC268641          DOI: 10.1128/jcm.23.2.354-359.1986

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  21 in total

1.  PHOSPHOLIPASE A ACTIVITY OF RAT-LIVER MITOCHONDRIA.

Authors:  C R ROSSI; L SARTORELLI; L TATO; L BARETTA; N SILIPRANDI
Journal:  Biochim Biophys Acta       Date:  1965-02-01

2.  Hydrolysis of phospholipids and glycerides by rat-liver preparations.

Authors:  M Waite; L L van Deenen
Journal:  Biochim Biophys Acta       Date:  1967-06-06

3.  Phospholipase C purification and specificity with respect to individual phospholipids and brain microsomal membrane phospholipids.

Authors:  W L Stahl
Journal:  Arch Biochem Biophys       Date:  1973-01       Impact factor: 4.013

4.  Hydrolysis of phosphatidylcholine liposomes by pancreatic phospholipase A2 at the transition temperature.

Authors:  J A Op den Kamp; J de Gier; L L van Deenen
Journal:  Biochim Biophys Acta       Date:  1974-04-29

5.  Differences in susceptibility to phospholipase C of free and membrane-bound phospholipids of Mycoplasma hominis.

Authors:  S Rottem; M Hasin; S Razin
Journal:  Biochim Biophys Acta       Date:  1973-11-16

6.  A membrane-bound lysophospholipase from Mycoplasma laidlawii strain B.

Authors:  L M van Golde; R N McElhaney; L L van Deenen
Journal:  Biochim Biophys Acta       Date:  1971-02-02

7.  Action of pancreatic phospholipase A2 on phosphatidylcholine bilayers in different physical states.

Authors:  J A Op den Kamp; M T Kauerz; L L van Deenen
Journal:  Biochim Biophys Acta       Date:  1975-10-06

8.  Exotoxin activity associated with the Legionnaires disease bacterium.

Authors:  W B Baine; J K Rasheed; D C Mackel; C A Bopp; J G Wells; A F Kaufmann
Journal:  J Clin Microbiol       Date:  1979-03       Impact factor: 5.948

9.  Lysosomal phospholipases A1 and A2 of bovine adrenal medulla.

Authors:  A D Smith; H Winkler
Journal:  Biochem J       Date:  1968-08       Impact factor: 3.857

10.  Phospholipase A activity in human and ovine uterine tissues.

Authors:  S A Grieves; G C Liggins
Journal:  Prostaglandins       Date:  1976-08
View more
  14 in total

1.  Characterization of phospholipase A1, A2, C activity in Ureaplasma urealyticum membranes.

Authors:  N S DeSilva; P A Quinn
Journal:  Mol Cell Biochem       Date:  1999-11       Impact factor: 3.396

2.  Inflammatory bronchopulmonary response of preterm infants with microbial colonisation of the airways at birth.

Authors:  P Groneck; B Goetze-Speer; C P Speer
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1996-01       Impact factor: 5.747

3.  Fatal ureaplasmal pneumonia and sepsis in a newborn infant.

Authors:  F Brus; W M van Waarde; C Schoots; S B Oetomo
Journal:  Eur J Pediatr       Date:  1991-09       Impact factor: 3.183

4.  Ureaplasma urealyticum pneumonia: experimental production and demonstration of age-related susceptibility.

Authors:  P T Rudd; G H Cassell; K B Waites; J K Davis; L B Duffy
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

Review 5.  The Human Ureaplasma Species as Causative Agents of Chorioamnionitis.

Authors:  Emma L Sweeney; Samantha J Dando; Suhas G Kallapur; Christine L Knox
Journal:  Clin Microbiol Rev       Date:  2016-12-14       Impact factor: 26.132

6.  Rapid screening assay for phospholipase C activity in mycoplasmas.

Authors:  N S De Silva; P A Quinn
Journal:  J Clin Microbiol       Date:  1987-04       Impact factor: 5.948

7.  Amniotic fluid neutrophils can phagocytize bacteria: A mechanism for microbial killing in the amniotic cavity.

Authors:  Nardhy Gomez-Lopez; Roberto Romero; Valeria Garcia-Flores; Yi Xu; Yaozhu Leng; Ali Alhousseini; Sonia S Hassan; Bogdan Panaitescu
Journal:  Am J Reprod Immunol       Date:  2017-07-13       Impact factor: 3.886

8.  Hyperoxia potentiates Ureaplasma urealyticum pneumonia in newborn mice.

Authors:  D T Crouse; G H Cassell; K B Waites; J M Foster; G Cassady
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

9.  Ureaplasma diversum infection in vitro alters prostaglandin E2 and prostaglandin F2a production by bovine endometrial cells without affecting cell viability.

Authors:  J J Kim; P A Quinn; M A Fortier
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

10.  Localization of endogenous activity of phospholipases A and C in Ureaplasma urealyticum.

Authors:  N S De Silva; P A Quinn
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.